Australia seems poised to experience innovative medication for weight issues: Retatrutide. This dual compound – targeting on both GLP-1 and GIP receptors – has remarkable results in international trials, pointing to meaningful drops in weight. While approval remains with TGA, several Australians dealing with being overweight are hoping for Reta… Read More